Many traumatic brain injuries result in significant communication impairment across a spectrum that can range from limited speaking to apparent disorders of consciousness such as comas.
|Videos|January 13, 2022
Inspirational Musings: Art and Family History
Author(s)Harold J. Bursztajn, MD
One doctor shares how family history and art have inspired him.
Advertisement
MORE THAN MEDICINE
Harold J. Bursztajn, MD, shares his love of art and family history, and how it inspires him daily.
Dr Bursztajn is associate professor of psychiatry at Harvard Medical School and practices clinical and forensic psychiatry in Cambridge, Massachusetts.
For more videos like this, see
Advertisement
Related to this article
Review the timeline for Igalmi in at-home treatment of agitation in bipolar disorder and schizophrenia.
Meta-analysis finds bright light therapy boosts remission and response in nonseasonal depression, offering a low-cost add-on to standard care.
Minerva Neurosciences webinar reported that roluperidone monotherapy improved primary negative symptoms and functioning in stable patients with schizophrenia who had a low relapse risk.
Teacher-recorded classroom engagement scores beat GPA at identifying middle schoolers who reported alcohol or cannabis use by eighth grade.
The FDA seems to have shelved the fast-track drug review initiative launched during the Trump administration.
Oveporexton (Orzeyful) is now available in the US by prescription for the treatment of narcolepsy type 1.
Explore the types of scams encountered in psychiatric practice in order to help identify those at risk.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Scams: What Psychiatrists Need to Know
2
FDA Shelves Fast-Track Drug Review Initiative
3
Reviewing Roluperidone as Treatment for Negative Symptoms in Schizophrenia
4
Major Depressive Disorder With Mixed Features: Diagnosis and Treatment
5